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In this paper, I analyze the commercialization of patents in the Swedish medicine & hygiene sector. A 
unique database makes it possible to use a new method, where I follow the commercialization process of 
individual patents. A surprisingly low share (10%) of the inventions was discovered at universities or in 
firms close to universities, although 1/3 of total R&D is undertaken at universities in Sweden. The 
commercialization rate is higher among small firms and entrepreneurs compared to medium-sized and 
large firms, but the success rate is lower for the former groups. With respect to mode of 
commercialization, 90% of the patents are commercialized in existing firms and only 10% in new start-
ups. Few patents are sold or licensed abroad, and even then, manufacturing of the invention often takes 
place in Sweden. It seems like there is a lack of external venture capital to a higher degree in the 
commercialization phase than in the R&D phase. Entrepreneurs and small firms often claim that financing 
and difficulties to find a firm willing to manufacture the invention are the largest problems during the 
commercialization, or the main reasons why the patent was not commercialized. The reasons why larger 
firms do not commercialize their patents are that they often give priority to other inventions, or utilize the 
patent as a “shadow patent” in order to prevent competitors to use the invention. 
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1. Introduction 
During recent years, inventions created through research and development (R&D) have 
become more important for firms’ competitiveness in strategic sectors like telecom, IT, 
medicine and biotechnology. A basic issue is how to facilitate the commercialization of 
the inventions created in the corporations and at the universities. 
Sweden is one of the countries in the world that spends most resources on R&D 
compared to GDP – both totally and in the universities (SOU 1996:70). Sweden is also 
top-ranked with respect to publications in international academic journals in relation to 
GDP (National Science Board, 1997), and granted patents per capita (EU, 2001). On the 
other hand, there are not so many small technology-based fast-growing firms in 
Sweden, which use the knowledge and innovations resulting from R&D effort. 
Apparently, the commercialisation of the patents and the intellectual capital does not 
work so efficiently in Sweden (Utterback and Reitberger, 1982; Rickne and Jacobsson, 
1996, 1999; Goldfarb and Henrekson, 2001). Other studies show that newly started 
technology-intensive firms originating from universities do not grow faster than other 
start-ups in Sweden (Olofsson and Wahlbin, 1993; Lindholm-Dahlstrand, 1997a, 
1997b). A comparison can be made with the US, which also spend large resources on 
R&D. In the US, however, there are many small firms, which – by basing their competi-
tiveness on innovations – have grown large in sectors like medicine, microbiology, IT 
and electronics. 
This paper is related to the phenomenon that Sweden has a leading position with 
respect to R&D, patents and publications, but not so many small fast-growing 
technology-based firms. The main purpose is to analyze the commercialization process 
of Swedish patents. Several questions related to the commercialization process are 
going to be analyzed: the mode of commercialization, financing of R&D and 
commercialization, whether the inventors are owners of the patent and have an active 
role during the commercialization, if there is no commercialization - why not? 
In order to get at better general picture of the patents, I have chosen a method 
where I follow how and if individual patents are commercialized. As nobody has used 
this method before, it is risky. Therefore, a pilot study is undertaken in a specific sector 
in Sweden – the medical and hygiene sector. Earlier Swedish studies of commercializa-
tion of inventions have only analyzed start-up firms, although a majority of the patents 
and inventions probably are commercialized in existing firms. In the US, for example, 
90% of the patents are commercialized in already existing firms (AUTM, 1998). 
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Furthermore, the interesting question is not whether inventions and patents lead to new 
firms, but whether they translate into a higher standard of living. 
The paper is organized as follows. Section 2 describes the database and sample 
selection. Some basic data about the inventions and patents is shown in section 3. In 
section 4, the choice to commercialize the patents is analyzed. In section 5, the mode 
and financing of the commercialization are investigated. Miscellaneous aspects of the 
commercialization are discussed in section 6, and the final section concludes. 
 
2. Database and sample selection 
When following the commercialization of patents, it would be desirable to have a 
database with information about individual patents, i.e., a database where the patent is 
the unit of observation. To the best of my knowledge, no such database has ever been 
collected before. Therefore, I decided to make a pilot study about the commercializa-
tion of patents in a specific sector in Sweden based on such a database. I chose granted 
patents in the medical & hygiene sector in 1994. This sector is known to be R&D-
intensive and is large enough to generate a large sample. I also chose the year 1994, 
because I expected that there are some years between the patent is granted and it is 
possible to see any effects of the commercialization. 
In 1994, 123 patents were granted in the medical & hygiene sector in Sweden. 
Information about inventors, applying firms and their addresses for each patent was 
bought from the Swedish Patent and Registration Office (PRV). Thereafter, a 
questionnaire was sent out to the inventors of the patents. Each patent has always at 
least one inventor and sometimes also an applying firm. The inventors or the applying 
firm can be the owner of the patent, but the inventors can also be owners of the patent 
indirectly, via the applying firm. Sometimes the inventors are only employed in the 
applying firm, which owns the patent. If the patent had more than one inventor, then the 
questionnaire was sent to only one inventor. In the questionnaire, which is fully 
described in the Appendix, we asked the inventors about the work place where the 
invention was created and the financing of the invention, whether the invention had 
been commercialized and in such a case how, how the commercialization was financed, 
about the inventors’ incomes and profits from the patent, and if there were any problems 
with the commercialization – alternatively, why the invention / patent never was 
commercialized. We also made telephone interviews with the inventors after they had 
filled in the questionnaire in order to get complementary information. 
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As many as 77 of the inventors filled in and returned the questionnaire, i.e., the 
response rate was 63% (77 of 123). This response rate is satisfactorily high, if one takes 
into account that such a database has never been collected before and that the inventors 
or the applying firms usually consider information about inventions and patents secret. 
  The reasons why 46 inventors did not fill in, and return, the questionnaire can be 
seen in Table 1. In this table, the inventors are sorted according to in which kind of firm 
they were employed when they made the invention. One main reason was that, in the 
case of large companies, the applying firm prohibited the inventors to fill in the 
questionnaire (10 lost observations). Large firms often consider information about 
patents as a company secret. Another problem was to get into contact with inventors, 
especially when they were alone and were not employed in any firm (17 lost obser-
vations). This is due to the fact that many of the addresses of the inventors, supplied by 




Table 2 describes how the response rate varies across different kind of firms where the 
inventors were active. The response rate is the lowest in the group where the inventors 
are alone (entrepreneurs) and when they own, or are employed in, a small firm. 
Although one group (medium-sized firms) has full response rate, this group is small and 
has only eight observations. We still believe that the sample is representative enough to 
make an appropriate analysis of the commercialization process. It is interesting to note 
that large firms account for only about 25% of the patents, both in the population 




When collecting the questionnaires, we sent out a reminder to those inventors who had 
not returned the questionnaire after three weeks. We contacted those inventors, who 
neither had replied after the reminder, by telephone. Sometimes we had to persuade 
them to fill in the questionnaire. When calling inventors who worked alone and asked 
them why they had not filled in, and returned, the questionnaire, many of them 
answered that there was no idea to participate in the investigation because they had 
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failed to make their invention profitable. By calling these inventors, we succeeded in 
including also such observations in the sample and to avoid a biased sample.  
  All in all, the questions in the questionnaire have a good response rate, given 
that the inventors have filled in and returned the questionnaire. The exception is the 
question about the inventor’s incomes or profits of the commercialization. Here, it was 
difficult for the inventors to estimate the volume of incomes, profits and fees. 
 
3. Inventions 
In Table 3, the 77 patents in the sample are distributed on the type of firm or place 
where the inventors were active when the invention was discovered. In this paper, we 
will frequently use this division of the patents on firm sizes, because this is perhaps the 
most important aspect when considering the conditions of commercialization. There is a 
huge difference in resources to commercialize patents between large firms, small firms 
and inventors who work alone, for example, with respect to financing, marketing and 
knowledge about rules and regulations.  
Large and medium-sized firms account for 20 and 8 patents, respectively. In 
these groups, the inventors are employed in the firm and not owners of the patent. In 
small firms and close companies, the inventors are, on the other hand, mostly owners of 
the patents directly or indirectly. These groups have 8 and 11 patents, respectively. The 
largest group is when the inventors are alone.  Here, 30 patents can be found, of which 
6 were in connection with a university. Remarkable is that only 8 patents (about 10%) 
were granted to inventors working at, or in a firm in connection with, a university.  I 
had expected a larger share, especially if one considers that almost 1/3 of total R&D in 




  However, the R&D undertaken in the universities does not need to result in 
patents at the universities. Jaffe (1989) has shown in an American study on state-level 
that university R&D may spillover in more industry R&D as well as in more patents in 
corporations in the same region. This result was especially found in the medicine and 
drugs industry. The mechanisms behind these spillovers would be informal conversa-
                                                 
1 Either as private individuals or in close companies where only the inventors are employed. 
2 One of the purposes when we planned this study was to analyse the commercialisation of inventions 
found in the university sector. The surprisingly few observations in this group made it, however, difficult 
to undertake an appropriate analysis. Therefore, we partly changed the contents of this study. 
3 This share is likely to be even higher in the medicine sector, based on the number of post-graduated 
researchers employed in corporations and at universities in the medicine sector in Sweden (SOU 
1996:70). 
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tions between universities and corporations, and that the universities supply a pool of 




In Table 3, it is also shown how the R&D that created the invention was financed. In 
large, medium-sized and small firms, the applying firm itself almost always finances the 
R&D behind the patent. In close companies, the inventors finance the R&D when they 
are sole owners. It is only in the last group (inventors alone) where there is some form 
of external financing to a larger degree – financing from the government, private 
venture capital firms or universities. In total, 14 patents had at least co-financing from 
external financing sources. 
  All 77 patents in the sample were granted in 1994, but the application year 
varied in the following way: 7 patent applications were filed in 1989, 9 in 1990, 9 in 
1991, 25 in 1992 and 27 in 1993. The average application year was 1992 and the 
average did not differ much across the five firm size groups. 
  In Table 4, the patents are distributed according to firm size and number of 
inventors. For most patents (47 of 77 patents), there is only one inventor, but on average 
there are almost two inventors per patent (126 inventors divided by 77 patents). Only 12 
out of 126 inventors, or 10 percent, were women. Furthermore, the women were mostly 





By commercialization of patents is meant that the owners of the patent have taken 
measures with the purpose to generate incomes from the patent. For the whole sample, 
34 out of 77 patents granted in 1994, or 44%, had started commercialization before 
2002. This is described in Table 5. In large and medium-sized firms, the commer-
cialization rate is only 25%, whereas the rate is significantly higher in smaller firms and 
when inventors are alone, and especially in close companies. 
An overall impression from numerous interviews with persons responsible for 
patents in large companies is that large companies to a high degree apply for patents in a 
defensive way – in order to prevent competitors from using the invention. Inventors 
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working in small firms or alone, on the other hand, say that the patent is more an 
opportunity to create a new product and open up new markets. The latter inventors are 
often optimistic about their inventions and often expect a high commercial potential. 
Sometimes they are too optimistic, which may explain the higher commercialization 
rate. 
There is also a significant difference in the rate of commercialization depending 
on whether the inventors were owners of the patent or not. If the inventors were owners, 
then 55% of the patents were commercialized compared to 27% if they were not 
owners. Also this difference may depend on the fact that the inventors are more 




The patents and the commercialization rate are also described across sectors in Table 6 
below. Medical facilities and hygiene articles are the largest groups, but the 
commercialization rate differs a lot across the groups. The rate is higher than average 
for the sectors drugs and substances, dentist tools and medical facilities. We will not 
undertake a deeper analysis of these differences, because we have chosen the firm size 




The reasons why patents had not been commercialized before 2002 are reported in 
Table 7. Here, the inventors could mention one or two different reasons. Difficulties to 
find financing or to find firms willing to manufacture the product as well as better 
competing products within the firm or by competitors dominate. Some patents are 
simply “shadow patents”, meaning that the owner apply for patents in order to deter 
competitors from utilizing the invention, and some patents are not ready for the market 
yet. It is obvious that the reasons differ depending on in which kind of firm the 
inventors were active. Large and medium-sized firms often have other inventions, 
which they prioritize, and have shadow patents. On the other hand, sole inventors have 
difficulties to find financing and firms that are willing to manufacture the product. 
Some inventors in small firms, close companies and who work alone have mentioned 
other problems with commercialization, which in my view are more related to starting a 
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small private firm or run business in general, for example, high taxes, bureaucracy and 
rigid rules for employment, etc. (see literature, e.g., Henrekson and Johansson, 1999). 
Since these problems are not specific for commercialization of patents, I do not show or 




Table 8 shows when commercialization started. On average, commercialization started 
in 1993, i.e., one year before the patents were granted. This is surprisingly fast. 
Although the average starting year varies across firm size, there is no obvious pattern. 
The distribution of starting years is shown in Figure 1. For 28 out of 34 patents, 
commercialization started between 1991 and 1995. As the application year was 1992 on 
average, this means that many owners began to commercialize their inventions already 
when they applied for the patent. Of the 43 patents that have not been commercialized 
yet, 29 are “dead” and 14 are “alive”, which means that they can still be commer-
cialized according to interviews with the inventors. My conclusion is, however, that 
most patents in the sample already have been commercialized if one expects some kind 






5. Mode and financing of the commercialization 
In Table 9, the mode of commercialization is described. Most of the patents (22 of 
them) were commercialized in existing or applying firms, where the inventors either 
were employed or owners. Only four patents were commercialized in a new firm started 
up with the purpose to commercialize the specific patent. This is about 10% of the 
commercialized patents and is in line with American studies, which have shown that 
90% of the patents are commercialized in existing firms (AUTM, 1998). In the Swedish 
debate, it is often claimed that patents are sold to foreign firms and commercialized 
abroad.
4 However, in this small sample, only three of the commercialized patents were 
                                                 
4 The fact that a patent is sold to a Swedish or foreign firm, may imply that the owners sold the whole 
firm, including the patent. 
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sold or licensed to foreign firms. Furthermore, one of the patents, which first was 
commercialized in an existing (applying) firm, was later sold to a foreign firm. The fact 
that a patent is sold or licensed to a foreign firm does not necessarily mean that the 
production of the invention takes place abroad. Of the four patents sold or licensed to 
foreign firms, only two were manufactured abroad (one in Holland and one in the U.S.), 
however, not shown in the table. Furthermore, one of the large Swedish firms 
manufactured one invention both in Sweden and in Holland. Thus, totally 3 out of 34 




Financing of the commercialization can be found in Table 10 below. The right side, 
where the inventors are owners of the patents, is the interesting part of the table.
5 Of 
these 26 patents, six were sold or licensed to other existing (Swedish or foreign) firms. 
In interviews, most of the inventors of these patents told me that selling or licensing the 
patent was the only way to finance the commercialization, or to find a firm willing to 
manufacture the product. For a vast majority of the patents, the owners must finance the 
commercialization themselves, either through loans, investment of own capital or 
reinvestment of profits from their existing firms. What is interesting, and surprising, to 
note here is the lack of government and private venture capital. Only for two patents 
(see notes 
a and 
c in the table), government or private venture capital firms were willing 
to invest capital for the commercialization. This can be compared with the financing of 
R&D behind the invention in Table 3. Then, government or private venture firms 
(partly) financed the R&D for 11 out of 77 inventions. The statistics is in line with our 
telephone interviews, where many inventors claim that it is easier to get external 
financing when the invention is detected than when the invention is going to be 
commercialized. Also other Swedish studies have claimed that there is a lack of venture 
capital for small firms in Sweden (Braunerhjelm, 1999; Braunerhjelm et al., 2001), 




                                                 
5 It is easier for an established firm to finance the commercialisation. 
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Whether the inventors were active or not during the commercialization phase is shown 
in Table 11. Almost all inventors were active during this phase, even if they were not 
owners of the firm or the patent. Also when the patent was sold or licensed (6 patents), 





In Table 12, we show the juridical type of firm, in which commercialization was 
undertaken when the inventors were owner of the firms. In small firms (not shown in 
the table) and close companies, the juridical type is always a limited company. When 
the inventors are alone, there is a larger variation in the type of firm. Often the firm is a 
trading company or a private firm. One can imagine that the inventors, who work alone, 
often have a permanent work somewhere else and the invention is often some kind of 





6. Incomes and performance 
In this section, I analyze incomes for the inventors and performance of the 
commercialization. As already mentioned in Section 2, the largest difficulties with the 
collection of information were to get good answers for the question related to the 
inventors’ incomes from the patent. When the inventors are not owners of the patent, it 
was no idea to ask about the firm’s incomes and profits, because they simply do not 
know. Therefore, I only asked about the inventors’ incomes. 
The inventors had often problems to estimate the incomes and profits. 
Sometimes the invention is a part of a larger system, meaning that it is difficult to know 
the incomes, even if the inventors also are the owners. We also asked about how many 
years of employment the patent had generated in Sweden after the commercialization 
had started – both inventors who were and were not owners. This question was easier to 
answer, although there could be problems when the invention is a part in a larger 
system. Anyway, we have tried to make a rough estimation of whether the performance 
of the commercialization was “Very good”, “Good”, “OK” or “Bad”. It is very easy to 
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conclude which patents have given nothing to the owners, or when the patent has been a 
loss. These patents are regarded to have a “Bad” performance. The other three groups 
are more difficult to categorize. For these three groups we have taken into account 
incomes, profits and takeover fees for the owners, as well as number of working years 
generated by the patent. It should also be noted that those patents that have not been 
commercialized almost always are a loss for the inventors, due to fees to PRV and 
patent bureaus, as well as time and resources spent to create the invention. An exception 
is when a large firm uses the patent as a shadow patent and then can deter competitors 
from entering the market. 
In Table 13, the performance of the commercialization is shown. The success 
rate is good in large, medium and small firms. For the group of close companies, the 
success rate is acceptable. However, for inventors working alone more than 50% of the 
patents is a loss for the inventors. There is an obvious trend in the table: the smaller the 
firm, the lower the success rate. Of the four patents commercialized in new firms, one 
had a very good, one had a good and two had a bad performance. If we look at the total 
sample of patents, also those patents, which were not commercialized, then 10 of 77 





Employment for the inventors during the commercialization and the number of working 
years generated in Sweden by the patent are shown in Table 14. In four groups, the 
inventors have got employment during the commercialization. For inventors, who work 
alone, the patent had generated paid employment for 3 out of 13 observations. However, 
if we look in the right part of the table, the patent can generate employment for other 
persons in Sweden, for example, if the patent is sold or licensed. As many as eight 
patents have generated more than 20 employment years in Sweden. Patents generating 
many jobs can also be found in the last group (inventors alone), but the probability that 
the patent generate many jobs increases with firm size. The worse performance of 
smaller firms and inventors who work alone can of course depend on that these 
inventors are overoptimistic about their inventions or that they have had problems to 
find financing and firms willing to manufacture the product (see Table 15 below). The 
34 commercialized patents generated 16,1 working years on average up to the year 
   11
2002. This high average depends on that three patents have generated at least 50 




In Table 15, it is shown which kind of problems that occurred during the commer-
cialization. As expected, smaller firms and inventors who worked alone had most 
difficulties. Financing seems to be the largest problem. This fact can be compared to 
Table 7, where the reasons why patents had not been commercialized were depicted. It 
seems also like many small inventors have been over-optimistic and have not been able 





7. Concluding remarks 
In this study, I have analyzed the commercialization of patents in Sweden. A unique 
database has made it possible for me to use a new method, where I follow the comer-
cialization process of individual patents. Since nobody has used this method before and 
information about patents often are kept secret by firms, the project was risky. There-
fore, we made a pilot study for patents granted in 1994 in the medicine & hygiene 
sector. However, the collection of information was satisfactorily successful. The 
response rate was 63%. This response rate can be improved considerably: 1) If one 
chooses patents granted in a later year, then it will be more easy to get into contact with 
the inventors. Most patents are anyway commercialized around the year when they were 
granted; and 2) Large firms are excluded in the sample, because these firms are 
reluctant to give information about patents. Furthermore, patents in large firms seldom 
lead to new start-up firms (at least in this survey), and large firms often apply for 
patents in order to deter competitors from using the invention (“shadow patents”). 
  The conclusions in this study are of course limited to a specific sector, but they 
are nevertheless interesting. A surprisingly low share (10%) of the inventions were 
discovered at universities or in firms close to universities, although 1/3 of total R&D are 
undertaken at universities in Sweden. The owners had started to commercialize 44% of 
the patents in the sample up to 2002. The commercialization rate is higher among small 
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firms and entrepreneurs (inventors who work alone) compared to medium-sized and 
large firms. This difference may depend on that small firms and inventors are more 
optimistic about their own inventions. 
Only 10% of the patents were commercialized in new start-ups, and 90% in 
existing firms. This is in line with American studies. Around 10% of the commer-
cialized patents are sold or licensed to foreign firms, and even then, manufacturing of 
the invention often takes place in Sweden. Small firms and inventors must almost 
always finance the commercialization themselves. It seems like there is a lack of 
external venture capital to a higher degree in the commercialization phase than in the 
R&D phase. Entrepreneurs and small firms often claim that financing and difficulties to 
find a firm willing to manufacture the invention are the largest problems during the 
commercialization, or the main reasons why the patent was not commercialized. The 
reasons why larger firm do not commercialize patents are that these firms have a basket 
of inventions and often give priority to some of the other inventions. They often utilize 
the patent as a “shadow patent” in order to prevent competitors to use the invention. 
The most difficult question to get information about was the inventors’ incomes 
and profits of the commercialization. It is not easy for the inventors to give appropriate 
information about incomes and profits. These measurements must be improved in a 
future study. However, a rough measure of performance showed that the success rate for 
commercialized patents is lower for small firms and individuals compared to larger 
firms. Another measure of performance, the number of employment years generated in 
Sweden by the patent, had a better response rate. The commercialized patents generated 
16 employment years on average. However, there was a large variation among the 
patents, where a few patents owned by large and medium-sized firms generated more 
than 50 employment years each. Also in this case, patents with few employment years 
could be found among small firms and inventors who work alone. 
One of the purposes when I planned this project was to compare the Swedish 
commercialization process with how patents at American universities are commer-
cialized. However, in our study we did not find enough with Swedish patents granted to 
individuals working at universities, or in firms close to universities to undertake such an 
analysis. In a future study with more observations this kind of analysis will be possible. 
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sick or dead 
Total 
Large firms (>1000 employees)  10  1  1  12 
Medium firms (101-1000 employees)  0  0  0  0 
Small firms (11-100 employees)  3  2  1  6 
Close companies (2-10 employees)  0  6  0  6 
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Table 2. Response rate across firm type, number of patents and percent. 
Filled in questionnaire  Type of firm where  
inventors were active 
Yes No 





Large firms (>1000 employees)  20  12    32    62 % 
Medium firms (101-1000 employees)    8    0      8  100 % 
Small firms (11-100 employees)    8    6    14    57 % 
Close companies (2-10 employees)  11    6    17    65 % 
Inventors alone (1-4 inventors)  30  22    52    58 % 
Total  77  46  123    63 % 
Note: If the inventors are the only employees in a firm, then the inventors belong to the group “Inventors 
alone”. Whether the inventors belong to the group “Inventors alone” or “Close companies” is sometimes 












 Table 3. Financing of inventions across firm type and inventor ownership, number and percent. 
Financing of invention (number of observations)   




















Inventors ≥ 50% 
Government ≤50% 
Inventors ≥50% 
Venture ≤ 50% 
Large firms  0%  20  19               1
Medium firms  0%    8  7               1
0%    1  1              
Partly    3  3              
 
Small firms 
100%    4  3               1
Not    1  1              
Partly    5  5              
 
Close companies 
100%    5                  5
Inventors alone  24                  15 1 4 4
- “ -, at university   
 
100%    6                 3 3
Total  77                  39 23 2 1 1 3 4 4
Inventor ownership                   
Owner  47  11                23 1 1 3 4 4
Not owner  30  28               1 1
Total  77                  39 23 2 1 1 3 4 4
Note: “Venture” means private venture capital firm. If the inventors are the only employees in a firm (e.g. a close company), then the inventors belong to the group 
“Inventors alone”. One of the large firms is a state-owned firm. In one of the medium-sized firms, invention was created at a university, but the research was sponsored, and 
the patent was owned, by the private firm. One of the small firms is located close to a university. 
 
 
    
Table 4. Number of inventors and female inventors for the patents, number and 
percent. 
Number of inventors for the patent  Type of firm 
where inventors 











Large firms   9   8  2   1  20  35   3   9 
Medium firms   4   2     2  8  16   0   0 
Small firms   5    1   2  8  16   2  12 
Close companies   8   1     2  11  18   0   0 
Inventors alone  21   8     1  30  41   7  17 
Total sample  47  19  3  8  77  126  12  10 
Note: The total number of inventors in each group is calculated as follows, with example for the group 





Table 5. Commercialized patents across firm type and inventor ownership, 
number of patents and percent. 
Number of patents 
    Commercialization 
 











Large firms  Not owner    5  15  20  25 % 
Medium firms  Not owner    2    6    8  25 % 
Not owner    0    1    1 
Partly owner    2    1    3 
 
Small firms 
Complete owner    2    2    4 
 
50 % 
Not owner    1    0    1 
Partly owner    4    1    5 
 
Close companies 
Complete owner    5    0    5 
 
91 % 
Inventors alone  11    13  24 
         - “ -     at university     
 
Complete owner    2    4    6 
 
43 % 
Total  34 43  77  44  % 
Inventor ownership  Yes  No  Total  Rate 
Owner 26  21  47  55  % 
Not owner    8  22  30  27 % 
Total  34 43  77  44  % 
Note: One of the large firms is a state-owned firm. In one of the medium firms, invention was created at a 
university, but the research was sponsored, and the patent was owned, by the private firm. One of the 
small firms is located in connection with a university. 
 
 
    
Table 6. Commercialized patents across sector, number of patents and percent. 
Number of patents 
  Commercialization 
Type of firm 
where inventors 
were active 




Hygiene articles     5  12  17  29 % 
Drugs and substances     5    2    7  71 % 
Medical apparatus and equipment     2    5    7  29 % 
Medical facilities   11    9  20  55 % 
Dentist tools, equipment and material  7  5  12  58 % 
Equipment for disabled persons  2  5   7  29 % 
Other   2  5   7  29 % 






Table 8. Year when commercialization started for patents granted in 1994, across 
firm type, years. 
Type of firm where inventors were active  Average year  First year  Last year 
Large firms  1995  1992  2000 
Medium firms  1991  1991  1991 
Small firms  1993  1991  1995 
Close companies  1992  1980  1994 
Inventors alone  1994  1990  1999 



















 Table 7. Reasons why the patent has not been commercialized, number. 
 



















Lack of financing for the commercialization          7  7 
Inventors could not find firm willing to manufacture the product      1    7  8 
The inventor or applying firm had better products  3  4      1  8 
Competitors had better products      2    3  5 
Product is not ready for commercialization yet  1    1  1  2  5 
“Shadow” patent  4        1  5 
Market was too small or demand was uncertain for the product  3  1  1    1  6 
External advice was necessary for commercialization          1  1 
Product was not good enough  1  1        2 
The invention was only a part in a larger product  1          1 
Users had difficulties to accept the product          1  1 
Total (number of reasons)  13            6 5 1 24 49
Note: For each patent, the inventor could mention one or two different reason why the patent has not been commercialized yet. This explains why the number of reasons is 





    
Table 9. Mode of commercialization of patents, across firm type and inventor 
ownership, number of patents. 
Patent sold to  Patent licensed to  Commercialization in 
Applying or existing firm  
Type of firm 
where inventors 




















Large firms    1  1      3    5 
Medium  firms         2   2 
Small firms    1      3      4 
Close 
companies 
    8  1  1  10 
Inventors alone  2    2       5*    2  11 
-“- at university        1      1    2 
Total  2 2 3 1 16  6  4  34 
Inventor 
ownership 
            
Owner  2 1 2 1      16*    4  26 
Not owner    1  1      6      8 
Total  2 2 3 1 16  6  4  34 






Table 10. Financing of the commercialization, number of patents. 
Inventors are not 
owners 
Inventors are owners   






















Large firms  3  2             5 
Medium firms  2               2 
Small firms      1  3         4 
Close 
companies 
1        4 
a  3    2
 b   10 
Inventors alone      5  1    4
 c 2 1  13 
Total sample  6 2  6  8  7  4  1  34 
Note: According to Table 9, a new firm was started when four patents were commercialized. Of these, 
one was financed through emission at the stock market; inventors borrowed capital for two patents, and 
for the last patent, inventors used their own capital. 
a For one patent in this group, a government capital venture firm financed 20% of the capital. 
b  For one of the patents in this group, 30% of the financing was the inventors’ own capital. 







    
Table 11. The role of the inventors during the commercialization, number of 
patents. 
Inventors’ role during commercialization 
Active Passive 




when patent was granted 
Owner  Not owner  Owner  Not owner 
Large firms  Not owner    5       
Medium firms  Not owner    2     
Partly owner  1  1       
Small firms 
Complete owner  2       
Not owner    1     
Partly owner  4       
 
Close companies 
Complete owner  5       
Inventors alone  7  1  1  1 
  -“-  at university 
 
Complete owner 
2      
Total sample  22 10  1  1 
Inventors’ ownership when patent was granted         
Owner 22  2  1  1 
Not owner    8     







Table 12. Juridical type of firm where commercialization took place, for the 
groups Close companies and Inventors alone, number of patents. 
Firm size  Juridical type of firm where 
commercialization took place 
Close company  Inventors alone 
 
Of which new firms 
Limited company  9  5  2 
Trading company    3  2 
Private firm *    2   
Limited partnership company    1   
Total 9  11  4 












    
 
Table 13. Performance of commercialization, number of patents. 
Performance  Type of firm where 
inventors were active 






Large firms  3    1  1  5  20 
Medium firms  1  1      2    8 
Small firms  1  2    1  4    8 
Close companies  2  2  4  2  10  11 
Inventors alone  3  3    7  13  30 
Total  10 8  5  12  34  77 
Note: “Very good” means that the patent has been very successful, for example, a lot of incomes or 
profits for the owners, and / or the patent has lead to many new jobs. “Good” means that the owners have 
had some success with the patent. “OK” is not a good performance, but neither a loss for the owners. 
With “Bad” is meant that the owners have made a loss for the patent, sometimes they have not had any 






Table 14. Employment for the inventors and working years generated by the 
patent, number of patents. 
Patent gave inventors 
employment during 
commercialization 
Number of working years generated  
in Sweden by the patent 
Type of firm 
where inventors 
were active 
Yes No  >20  16-20  11-15  6-10  1-5  <1 
Large firms    5    3          1  1 
Medium firms    2    1  1         
Small firms    3    1  1      2    1   
Close companies  10    1  1  1  1    6   
Inventors alone    3  10  2  1  1      3  6 




















 Table 15. Difficulties when commercializing the patent, number. 
 



















Financing of the commercialization      1  3  4  8 
Difficult to find firm willing to manufacture the product          1  1 
High fees for patents and to patent bureaus         3    3 
Product was not good enough  1  1      3  5 
Scarce with time             1  1 
Users were reluctant to accept the product      1    2  3 
Difficult to find the right employees           2     2 
The inventor or applying firm had better products      1      1 
Cartel among existing firms in the market            1  1 
Inventor cheated by the producer           1  1 
Inventor had disease             1  1 
No difficulties  4            1 1 2 2 10
Total (number of reasons)  5            2 4 10 16 37
Note: For each patent, the inventor could mention one or two different problems for the commercialization. This explains why the number of problems is large than the 










Commercialization of Swedish Patents          Confidential 
 
1. Basic information about the patent.  Identity No. (PRV)   
Name of the patent    
Sector  Medicine & hygiene  Sub sector   
Year of application    Year when the patent was granted  1994 
Inventor(s)  
Applying firm   
The inventors’ share of ownership in the firm when the patent was granted.                                 %
The inventors’ and the applying firm’s ownership of the patent, when it was granted. 
Percent  Inventors                %  Applying firm                   % 
 
2. Type of work place where the invention was created. Mark with one cross. 
University (name)……………………………………………….   
Private firm (in connection with university……………..……………….)   
Private firm (not in connection with university)   
Government firm or authority   
Other work place (mention which)…………………………………..   
 
3. Financing of the invention until the application was filed. Percent. 
Government research foundation  % University  %
Private research foundation  % Inventors’ own capital  %
Applying firm  % Private venture capital  %
Other private firm  % Government venture capital  %
Other financing (state which)……………………………………………..  %
 
Yes No  4. Has the commercialization of the patent started? Mark with one cross. 
     Definition. With the term ”Commercialization” is here meant that measures have           
     been taken in order to generate incomes from the patent (see question 5b). 
  
 
If “Yes” in question 4 then questions 5-9 should be answered, if “No” go to question 10. 
 
5a. Which year started the commercialization? 
      Note! The commercialization may have started before the patent was granted. 
 
5b. Which mode of commercialization was used? Mark  
       with one cross and state the name of the buyer if the patent was sold. 
Buyer X 
The patent was sold to another existing Swedish firm     
The patent was sold to another existing foreign firm     
The patent was commercialized in a new firm (started up for this patent) where the 
inventors are owners 
 
The patent was commercialized in existing firm where the inventors are owners  
The patent was commercialized in existing firm where the inventors are employed  
The patent was licensed to another Swedish firm   
The patent was licensed to another foreign firm   
The inventors sold consulting services based on the patent   
Other alternative (mention which) ……………………………………………   
5c. Has the situation in question 5b changed since the start? If Yes,    
       mark with one cross and state year and buyer if any. 
Buyer (if any)  X  Year 
The new / existing firm was sold to a Swedish firm       
The new / existing firm was sold to a foreign firm       
Other alternative (mention which)…………………………..……        
6. If the commercialization was started in a new or existing firm where the inventors are owners,  
    how was the commercialization financed? Percent. 
Inventors’ own capital                   % 
Private venture capital (state source) ……………………………………………..                   % 
Government venture capital (state source) ……………………………………………                   % 
Existing firm’s capital                   % 
Inventors borrowed capital                   % 
Other financing (state which) …………………………………………                  %
 
7a. The role of the inventors during the commercialization. Mark with one cross. 
Active role and owner    Owner but not active role   
Active role but not owner    Neither active role nor owner   
7b. If the inventors were owners when commercialization started, state juridical firm and  
      ownership. 
Limited    Trading company    Other type of firm …….…….    Ownership          %
7c. Has the type of firm, the inventors’ ownership or role changed? State when and how. 
 
 
8. State the incomes / profits, which the patent up to now has generated for the  
    inventors and / or for the firm, which is owned by the inventors. 
SEK 
Incomes when the patent or firm was sold   
Incomes in existing or new firm   
Profits in existing or new firm   
Royalties  
Incomes from consulting services   
Other incomes (mention which)………………………………………..   
 
9. How many employment years has the patent generated in Sweden since the    
    commercialization started? (If 5 persons were employed in 4 years, then 20 years.) 
            years 
 
10. In which other countries and regions (also patent offices, e.g., EPO) has the invention     
      been granted a patent? 
         
         
 
11a. Has the invention been manufactured in other countries than Sweden?   Yes    No   
   11b. If “Yes”, mention countries and     
        starting year.    
 




12b. If the patent was not commercialized: Why not? State one or two reasons. 
 
 
 
 